Search - tctmd.com

Displaying 961 - 980 of 1181

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Intravascular Lithotripsy Facilitated Transfemoral TAVR After Subclavian Arterial Access Failure

Presenter: Howard C. Herrmann, Fabian Nietlispach, Chandan Devireddy, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Philipp Blanke

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #3: A Small (Undersized) Surgical Bioprosthesis

Presenter: Michael J. Reardon, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Presenter: Brian K. Whisenant, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Case #1: A Poorly Visible Surgical Bioprosthesis

Presenter: Isaac George, Adnan K. Chhatriwalla, Danny Dvir, Ariel Finkelstein, Kendra J. Grubb, Michael J. Mack, Thomas Modine, Mark J. Russo

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the PARTNER Aortic Valve-in-Valve Registry

Presenter: Vinayak Bapat, Ran Kornowski, Michael J. Mack

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Vinayak Bapat, Ran Kornowski, Danny Dvir

June 21, 2018

News Daily News

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

Yael L. Maxwell

June 20, 2018

Presentation

Failure to Rescue, Hospital Volume, and In-Hospital Mortality After TAVR

June 20, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Shelley Wood

June 18, 2018

News Daily News

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

L.A. McKeown

June 12, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

Caitlin E. Cox

May 24, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News SCAI 2018

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

Shelley Wood

April 27, 2018

Advertisement

Intravascular Lithotripsy Facilitated Transfemoral TAVR After Subclavian Arterial Access Failure

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

How to Screen for Risk of Coronary Obstruction Risk on CT Prior to Aortic Valve-in-Valve Procedures

Case #3: A Small (Undersized) Surgical Bioprosthesis

Case #2: A Stentless (or Stented With Leaflets Outside the Stent) Surgical Bioprosthesis

Case #1: A Poorly Visible Surgical Bioprosthesis

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Updates from the PARTNER Aortic Valve-in-Valve Registry

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

‘Failure to Rescue’ Doesn’t Fully Explain Higher Mortality at Lower-Volume TAVR Centers

Failure to Rescue, Hospital Volume, and In-Hospital Mortality After TAVR

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Burden of Anticoagulation Can Be Reduced in Some Patients With Mechanical Valves

Pace Quickens for Mitral Device Innovation for Repair, Replacement

NOTION: TAVR in Low-Risk Patients Maintains Its Momentum Through 6 Years

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content